Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2020

Nov 13, 2020

SELL
$93.53 - $163.34 $1.02 Million - $1.78 Million
-10,900 Closed
0 $0
Q1 2020

May 08, 2020

BUY
$124.16 - $247.74 $1.35 Million - $2.7 Million
10,900 New
10,900 $198,000
Q4 2019

Feb 11, 2020

SELL
$74.57 - $217.92 $2.8 Million - $8.17 Million
-37,500 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$71.26 - $95.75 $2.67 Million - $3.59 Million
37,500 New
37,500 $703,000

Others Institutions Holding RETA

About REATA PHARMACEUTICALS INC


  • Ticker RETA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 31,583,200
  • Description
  • Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...
More about RETA
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.